Bioventix (LON:BVXP) Stock Price Passes Above 50 Day Moving Average – Should You Sell?

Bioventix PLC (LON:BVXP)’s share price passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of GBX 2,713.11 ($36.81) and traded as high as GBX 2,800 ($37.99). Bioventix shares last traded at GBX 2,655 ($36.02), with a volume of 1,838 shares.

Bioventix Trading Down 3.5%

The stock has a market cap of £139.02 million, a P/E ratio of 17.17 and a beta of 0.35. The business has a 50-day simple moving average of GBX 2,713.11 and a 200 day simple moving average of GBX 2,945.64.

Bioventix (LON:BVXP) last posted its quarterly earnings results on Monday, March 31st. The biotechnology company reported GBX 72.27 ($0.98) earnings per share (EPS) for the quarter. Bioventix had a net margin of 59.51% and a return on equity of 69.09%. As a group, equities analysts expect that Bioventix PLC will post 166.3066955 earnings per share for the current year.

Bioventix Cuts Dividend

The company also recently disclosed a dividend, which was paid on Friday, April 25th. Investors of record on Thursday, April 10th were paid a GBX 70 ($0.95) dividend. This represents a yield of 2.95%. The ex-dividend date was Thursday, April 10th. Bioventix’s dividend payout ratio is currently 102.19%.

Insider Buying and Selling

In other Bioventix news, insider Bruce Hiscock acquired 31 shares of the business’s stock in a transaction dated Monday, April 28th. The stock was bought at an average price of GBX 2,632 ($35.71) per share, with a total value of £815.92 ($1,107.08). 8.02% of the stock is currently owned by insiders.

Bioventix Company Profile

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.